Medifreeze TaLachaim
Stem Cell Cryopreservation
Startup Mature Health Tech & Life Sciences Est. 2004
🌐 Website
Total Raised
$1M
Mature
Last Round
$1M
1 rounds
Investors
2
2 public
Team
2
1-10 employees
Confidence
80/100
About
Medifreeze TaLachaim is a cryopreservation company operating the cord blood bank from Hadassah Medical Center. The Medifreeze TaLachaim lab produces stem cells from a newborn's umbilical cord blood using the Sepax device.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
BiologicalsCells
Target Customer
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareLaboratories
Business Model
B2C
Tags
stem-cellsbiotechnologylife-sciencesgenetic-engineeringmedical-technologiesparents
Funding & Events
Jul 2011
Seed $1M
Daniel Recanati, Zelig Associates
Details
Product Stage
Released
Employees
1-10
Exact Count
6
District
Center District
Founded
2004
Registrar
513412916
Locations
Hahilazon 3, Ramat Gan, Israel
Links
Website
www.talachaim.co.il/english
Facebook
Page
Admin
Last Update
Sep 14, 2024
Verified by
Jenny Sotnik-Talisman
Missing
description, video or image, news, markets, not claimed
Team (2)
Ynon Taub
Co-founder & CEO
Founder
Hagay Avisar
Co-founder
Founder
Internal
Created by
Natalia Golczar (ngolczar@gmail.com)
Created
2018-07-18T00:00:00.000Z
Last editor
Anna Gutarts-Habas (annagutarts@gmail.com)
Finder · Medifreeze TaLachaim · 2026